Literature DB >> 11502949

Resolving disparities in antidepressant treatment and quality-of-life outcomes between uninsured and insured primary care patients with depression.

J L Smith1, K M Rost, P A Nutting, C E Elliott.   

Abstract

BACKGROUND: Efforts to improve primary care depression treatment should penetrate to vulnerable uninsured populations.
OBJECTIVE: To assess a primary care intervention's impact on treatment and quality-of-life outcomes in uninsured and insured depressed patients during the acute treatment phase. RESEARCH
DESIGN: Twelve community primary care practices were randomized to 'enhanced' (intervention) and usual care conditions. Physicians, nurses and administrative staff in enhanced care practices received training to improve detection and management of depression.
SUBJECTS: In 1996 to 1997, 383 nonelderly depressed patients who were either uninsured or covered by private insurance/Medicaid were enrolled; 343 (89.6%) completed six-month follow-up. MEASURES: Adequate pharmacotherapy (>or=3 months of antidepressants at therapeutic doses); adequate psychotherapy (>or=8 counseling visits); improvement in mental-health-related-quality-of-life (MHQOL), assessed by Mental Component Summary scale for SF-36.
RESULTS: Multivariate results showed that 54.6% of uninsured enhanced care (UEC) patients received adequate pharmacotherapy, compared with 14.3% of uninsured usual care (UUC) patients (P = 0.0005); however, receipt of adequate psychotherapy was comparable between these two groups (18.2% UEC, 11.9% UUC; P = 0.42). Intervention effects on insured patients' treatment were modest to minimal. Among usual care patients, the insured had 5.4 points greater improvement in MHQOL at 6 months than the uninsured (12.4 points insured, 7.0 points uninsured; P = 0.02); however, among patients receiving the intervention, the insured and uninsured had comparable MHQOL improvement (12.3 points insured, 11.6 points uninsured; P = 0.76).
CONCLUSIONS: The intervention improved antidepressant treatment rates in uninsured patients and helped resolve quality-of-life outcome disparities observed between insured and uninsured patients receiving usual care.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11502949     DOI: 10.1097/00005650-200109000-00002

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  7 in total

1.  So much to do, so little time: care for the socially disadvantaged and the 15-minute visit.

Authors:  Kevin Fiscella; Ronald M Epstein
Journal:  Arch Intern Med       Date:  2008-09-22

2.  Barriers to initiating depression treatment in primary care practice.

Authors:  Paul A Nutting; Kathryn Rost; Miriam Dickinson; James J Werner; Perry Dickinson; Jeffrey L Smith; Beth Gallovic
Journal:  J Gen Intern Med       Date:  2002-02       Impact factor: 5.128

3.  Quality of life in tuberculosis: patient and provider perspectives.

Authors:  Nadia N Hansel; Albert W Wu; Betty Chang; Gregory B Diette
Journal:  Qual Life Res       Date:  2004-04       Impact factor: 4.147

4.  Racial and Ethnic Disparity in Major Depressive Disorder.

Authors:  Zhili Shao; William D Richie; Rahn Kennedy Bailey
Journal:  J Racial Ethn Health Disparities       Date:  2015-12-16

5.  Care management for depression in primary care practice: findings from the RESPECT-Depression trial.

Authors:  Paul A Nutting; Kaia Gallagher; Kim Riley; Suzanne White; W Perry Dickinson; Neil Korsen; Allen Dietrich
Journal:  Ann Fam Med       Date:  2008 Jan-Feb       Impact factor: 5.166

6.  Telephone and in-person cognitive behavioral therapy for major depression after traumatic brain injury: a randomized controlled trial.

Authors:  Jesse R Fann; Charles H Bombardier; Steven Vannoy; Joshua Dyer; Evette Ludman; Sureyya Dikmen; Kenneth Marshall; Jason Barber; Nancy Temkin
Journal:  J Neurotrauma       Date:  2015-01-01       Impact factor: 5.269

7.  Anthroposophic therapy for chronic depression: a four-year prospective cohort study.

Authors:  Harald J Hamre; Claudia M Witt; Anja Glockmann; Renatus Ziegler; Stefan N Willich; Helmut Kiene
Journal:  BMC Psychiatry       Date:  2006-12-15       Impact factor: 3.630

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.